OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhostUNIVERSITÄT DORTMUND

Select item for more details and to access through your institution.

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.
Published in:
Breast Cancer Research & Treatment, 2021, v. 188, n. 3, p. 631, doi. 10.1007/s10549-021-06240-5
By:
- Stebbing, Justin;
- Baranau, Yauheni V.;
- Baryash, Valery;
- Manikhas, Alexey;
- Moiseyenko, Vladimir;
- Dzagnidze, Giorgi;
- Zhavrid, Edvard;
- Boliukh, Dmytro;
- Pikiel, Joanna;
- Eniu, Alexandru E.;
- Li, Rubi K.;
- Tiangco, Beatrice;
- Lee, Sang Joon;
- Kim, Sunghyun
Publication type:
Article
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.
Published in:
BioDrugs, 2023, v. 37, n. 3, p. 433, doi. 10.1007/s40259-023-00582-w
By:
- Stebbing, Justin;
- Baranau, Yauheni;
- Baryash, Valery;
- Moiseyenko, Vladimir;
- Boliukh, Dmytro;
- Antone, Nicoleta;
- Manikhas, Alexey;
- Chornobai, Anatolii;
- Park, Taehong;
- Baek, Eric Hyungseok;
- Lee, Jaeyong;
- Choi, Jiin;
- Kim, Nahyun;
- Ahn, Keumyoung;
- Lee, Sang Joon;
- Kim, Sunghyun
Publication type:
Article